Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity
Ericka Kirkpatrick, Carole Henry, Meagan McMahon, Kaijun Jiang, Shirin Strohmeier, Harm van Bakel, Patrick C. Wilson, Florian Krammer
Abstract
Understanding the immune response that older individuals mount to influenza virus vaccination and infection is critical in order to design better vaccines for this age group. Here, we show that older individuals make broadly neutralizing antibodies that have no hemagglutination-inhibiting activity and are less potent than strain-specific antibodies. These antibodies could drive viral escape from neutralization but did not result in escape from binding. Given their different mechanisms of action, they might retain protective activity even against escape variants.
Topics & Concepts
Hemagglutinin (influenza)BiologyVirologyHemagglutination assayHemagglutinationAntibodyInfluenzavirus BVirusInfluenza A virusOrthomyxoviridaeH5N1 genetic structureMicrobiologyCoronavirus disease 2019 (COVID-19)ImmunologyTiterDiseaseInfectious disease (medical specialty)MedicinePathologyInfluenza Virus Research StudiesSARS-CoV-2 and COVID-19 ResearchHepatitis B Virus Studies